Founder, Chairman, Chief Scientific Advisor and Chairman of Medical and Scientific Advisory BoardDr. Allan L. Goldstein Ph.D. is Chairman of the Board, Chief Scientific Advisor of the Company. He is Emeritus Professor former Chairman of the Department of Biochemistry and Molecular Medicine at the George Washington University School of Medicine and Health Sciences. Dr. Goldstein is a recognized expert in the field of immunology and protein chemistry, having authored over 435 scientific articles in professional journals. He is also the inventor on over 25 issued andor pending patents in biochemistry, immunology, cardiology, cancer and wound healing. Dr. Goldstein discovered several important compounds, including Ta1, which is marketed worldwide, and Tb4, which is the basis for RegeneRxs clinical program. Dr. Goldstein served on the Board of Trustees of the Sabin Vaccine Institute from 2000 to 2012 and on the Board of Directors of the Richard B. and Lynne V. Cheney Cardiovascular Institute from 2006 to 2012
Age: 77 Chairman Since 1982Goldstein has also done pioneering work in the area of medical education, developing distance learning programs for the internet entitled ?Frontiers in Medicine, ? a medical education series that Dr. Goldstein developed. The Board believes that Dr. Goldstein?s scientific expertise, industry background and prior experience as our founder all position him to make an effective contribution to the medical and scientific understanding of the Board, which the committee believes to be particularly important as we continue our Tb4 development efforts.